Oli Pharma Llp - Company Profile

It is a business services limited liability partnership based in Delhi, Delhi, India, established in 2022.
2022 Delhi, Delhi, India Active
Last Updated:
Access Report
About Oli Pharma Llp

Oli Pharma Llp, a active limited liability partnership, was established on 13 December 2022 in Delhi, Delhi, India. Engaging in commission trade within the business services sector, it holds LLPIN: ABZ-4339. Registered under ROC Roc Delhi. It has total obligation of contribution of ₹0.10 M.

Its leadership includes Jagmeet Singh (Designated Partner), Shashank Kaushik (Designated Partner). Past directors included Priyanshi Garg, Rahil Chaudhary. It holds ₹2.00 Cr open charges and no settled loans. Its latest date of accounts and solvency statement 31 March 2025. It is based at 2/47-A 2Nd Floor, Vijay Nagar, Delhi, Delhi, 110009.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    ABZ-4339

  • Incorporation Date

    13 December 2022

  • Total Obligation of Contribution

    ₹0.10 M

  • ROC Code

    Roc Delhi

  • Company Status

    Active

Key Metrics
  • Obligation of Contribution ₹ 0.10 M
  • Company Age 3 Year, 4 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 2.00 Cr
Company report

Oli Pharma Llp

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into Oli Pharma Llp — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Oli Pharma Llp?
Current Designated Partners
Name Designation Appointment Date Status
Jagmeet Singh Designated Partner 15 Apr 2023 Current
Shashank Kaushik Designated Partner 13 Dec 2022 Current
Past Designated Partners
Name Designation Cessation Status
Pramod Abcsdd - 15 Apr 2023 Past
Pramod Abcsdd Partner - Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Oli Pharma Llp.

Enhance accessibility to Oli Pharma Llp's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Oli Pharma Llp revenue growth over time
Oli Pharma Llp profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Oli Pharma Llp?

Unlock access to Oli Pharma Llp's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹20,000,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • Idbi Bank Limited : 2.00 Cr
Latest Charge Details
Date Lender Amount Status
14 Oct 2025 Idbi Bank Limited ₹2.00 Cr Open

Explore comprehensive loan charge details -

How Many Employees Work at Oli Pharma Llp?

Unlock and access historical data on people associated with Oli Pharma Llp, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Oli Pharma Llp, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Oli Pharma Llp's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Oli Pharma Llp
Recent Activity within the Organization
  • Charges

    A charge with Idbi Bank Limited amounted to Rs. 20.00 M with Charge ID 101168930 was registered on 14 Oct 2025. was recorded as a recent event.

  • Annual General Meeting

    The activity Oli Pharma Llp last Annual general meeting of members was held on 31 Mar 2025 as per latest MCA records. was completed.

  • Statement of Assets & Liabilities

    Progress on Oli Pharma Llp has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi. was documented.

  • Director Appointment

    Jagmeet Singh was appointed as a Designated Partner was appointed as a Designated Partner on 15 Apr 2023 & has been associated with this company since 3 years 8 days . was recorded as a recent event.

  • Director Appointment

    Progress on Shashank Kaushik was appointed as a Designated Partner was appointed as a Designated Partner on 13 Dec 2022 & has been associated with this company since 3 years 4 months . was documented.

  • LLP Incorporation

    Progress on Oli Pharma Llp was registered on 13 Dec 2022 with Roc Delhi & aged 3 years 4 months as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the LLPIN of Oli Pharma Llp?

The LLPIN of Oli Pharma Llp is ABZ-4339.

Where is Oli Pharma Llp headquartered?

Oli Pharma Llp is headquartered at 2/47-A 2Nd Floor, Vijay Nagar, Delhi, Delhi, 110009.

When was Oli Pharma Llp incorporated?

Oli Pharma Llp was incorporated on 13 December 2022.

Who are the current directors of Oli Pharma Llp?

The current directors of Oli Pharma Llp are

What is the primary industry of Oli Pharma Llp?

The primary industry of Oli Pharma Llp is Business Services.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available